ANC

Nov 27 2024SCIENCE

New Hope in Leukemia Fight: The First BRD4 BD2-Selective Inhibitor

Imagine being able to target a specific part of a protein to fight leukemia with less side effects. That's what scientists are working on with a new drug called XY221. This drug, XY221, is special because it sticks to a tiny part of a protein called BRD4 BD2. This part is like a keyhole, and XY221 i

reading time less than a minute
Nov 27 2024BUSINESS

Top Pick: UseNosh Shines in Gift Card Trading Survey

In a recent survey by Techpoint, a well-known tech media outlet in Nigeria, the digital finance platform UseNosh has been ranked as a leading player in the gift card trading market. This achievement isn't surprising, considering the company's efforts to improve its services and offer better value to

reading time less than a minute
Nov 27 2024HEALTH

Fueling Up in the Heat: How Food and Supplements Boost Heat Exercise

As the planet warms up, so do the temperatures. This means more people are getting sick or worse from high temperatures. Scientists have found that picking the right foods and supplements can help us perform better and stay healthier when we exercise in the heat. This review discusses a bunch of way

reading time less than a minute
Nov 27 2024HEALTH

Cough Relief with Pregabalin in Lung Cancer Patients: A Clinical Trial

You might not know this, but coughing all the time can be really tough. For people with lung cancer, this is a daily struggle. Medications that can help are in short supply. That's where a drug called pregabalin comes in. Scientists wanted to see if this drug could help suppress coughs. They designe

reading time less than a minute
Nov 27 2024HEALTH

Palbociclib and Letrozole: New Hope for Breast Cancer Patients with Residual Disease

In the fight against breast cancer, doctors are constantly searching for better ways to treat the disease. One recent study, known as the PROMETEO II trial, looked into combining two drugs - palbociclib and letrozole - to help patients with a specific type of breast cancer. This type of cancer is ho

reading time less than a minute
Nov 27 2024FINANCE

Ivancevic Model: A Wave-Based Examination of Option Pricing

Ever wondered how the price of an option can be predicted using waves? Meet the Ivancevic Option Pricing Model, a different take from the classic Black-Scholes model. This model uses complex equations, called adaptive nonlinear Schrödinger equations, to describe waves influenced by stock prices over

reading time less than a minute
Nov 27 2024BUSINESS

Kohl's Stock Takes Hit as CEO Exits and Sales Slide

Kohl's shares took a big hit, dropping over 20%, after the company's sales plummeted and its CEO suddenly left. The department store, based in Wisconsin, reported that sales in existing stores fell by nearly 10% for the third quarter in a row. This is a tough blow, especially coming just before the

reading time less than a minute
Nov 27 2024POLITICS

Rudy Giuliani’s Courtroom Outburst: Unable to Pay Bills

In a heated courtroom exchange, former New York Mayor Rudy Giuliani, now 80, vented his frustrations, admitting he couldn't pay his bills. This dramatic moment happened during a federal court hearing in Manhattan, where Giuliani was dealing with a massive $150 million judgment for defamation. Two Ge

reading time less than a minute
Nov 27 2024CELEBRITIES

Catching Up with Bhad Bhabie: The Young Rapper's Health Journey

Young rapper Bhad Bhabie, real name Danielle Bregoli, has been in the spotlight since 2016 when she went viral on Dr. Phil with her iconic "Catch me outside, how 'bout that? " line. Recently, she's been making headlines again, but this time it's about her health. While heading to LAX, she was approa

reading time less than a minute
Nov 27 2024HEALTH

New Drug Discovery: Combining Eugenol and Benznidazole to Fight Chagas Disease

Imagine mixing two powerful substances to create a superhero drug against a dangerous disease. That's what scientists have done by combining eugenol and benznidazole to fight Chagas disease. This illness, caused by the protozoan Trypanosoma cruzi, has only two treatment options—benznidazole and nifu

reading time less than a minute